(2/2) CDU/UCLA Cancer Center Partnership to Eliminate Cancer Health Disparities
(2/2) CDU/UCLA Cancer Center Partnership to Eliminate Cancer Health Disparities
批准号:
10247107
负责人:
Richard Joseph Pietras
金额:
$34.5万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-29 至 2021-08-31
关键词:
AddressAreaAwardCaliforniaCancer BurdenCancer CenterCancer Research InfrastructureCancer Research ProjectCatchment AreaClinicalClinical ResearchClinical TrialsCollaborationsCommunitiesCommunity OutreachComprehensive Cancer CenterCounselingCountyDatabasesDevelopmentEducationEducation and OutreachEvaluationFacultyFocus GroupsFundingGoalsGrantHealthHispanic-serving InstitutionHistorically Black Colleges and UniversitiesIncidenceInfrastructureInstitutionInvestmentsLinguisticsLos AngelesMalignant NeoplasmsMedical StudentsMedicineMentorsMentorshipMinorityMinority-Serving InstitutionMississippiNCI-Designated Cancer CenterNational Cancer InstituteOutcomePilot ProjectsPopulationPostdoctoral FellowPrevention strategyProgram DevelopmentResearchResearch PersonnelResearch Project GrantsResource SharingResourcesRiversScienceScientistStudentsTrainingTraining and InfrastructureUnderrepresented MinorityUnderrepresented PopulationsUnderserved PopulationUniversitiesanticancer researchbiobankcancer educationcancer health disparitycareercareer developmentclinical biomarkersdata resourcedemographicseducation researchhealth disparityhealth equityinstitutional capacityminority investigatorminority studentoutreachprogramspublic health relevancerecruitresearch facilitysocioeconomic disadvantagesuccesstissue biomarkerstissue resourceundergraduate student
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant) : The Charles R. Drew University (CDU) and the UCLA Jonsson Comprehensive Cancer Center has forged a strong and sustainable partnership to "Eliminate Cancer Health Disparities in minority and underserved populations". Our partnership began in 2003 with support from the National Cancer Institute to initiate U56 collaboration, followed by a U54 award in 2009 to establish a long lasting comprehensive partnership. In addition, institutional investment from UCLA-JCCC and CDU has made it possible for a sustainable partnership to accomplish significant goals related to reducing cancer health disparities. Hence, in our renewal application, we propose to continue the momentum and do more to address cancer health disparities in our communities in Los Angeles County, and in particular South Los Angeles. The overarching goals of the CDU-UCLA Cancer Partnership Program are to significantly increase the number of scientists in cancer research and to enhance the cancer research and infrastructure capacity at Charles Drew University of Medicine and Science that will continue to address significant disparities in cancer among minority populations. Supported and implemented by an Administrative Core, Planning and Evaluation Core, and Research Projects, Research Education Core, Outreach Core, and Shared Resources Core. The five priorities for the partnership are: Priority 1: Increase the number and quality of cancer research projects at CDU by supporting full and pilot projects and increase the number of cancer researchers at CDU. Priority 2: Enhance research capability of the CDU's Integrated Clinical and Biomarker/ Biorepository Tissue and Data Resources focused on cancer health disparities research, education and outreach among underrepresented populations. Priority 3: Create institutional capacity at CDU for performing cancer-related clinica trials by leveraging the community and existing clinical research facilities and resources. Priorit 4: Expose undergraduate and medical students, fellows, and faculty to cancer research and encourage them to pursue or advance their careers in this area, and implement a formalized mentorship program whereby junior research investigators are counseled and mentored during their career development. Priority 5: Bring culturally and linguistically appropriate cancer research information to the community and increase community capacity to develop and implement culturally appropriate health prevention strategies through community-partnered participatory research.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.4172/2329-8820.1000122
发表时间:
2013-05-23
期刊:
Journal of bone marrow research
影响因子:
--
作者:
[Mathews LA, Hurt EM, Zhang X, Farrar WL]
通讯作者:
Farrar WL
DOI:
10.17303/jcrto.2020.8.206
发表时间:
2020-04-01
期刊:
Journal of cancer research and therapeutic oncology
影响因子:
--
作者:
[DeAngelo, Christopher, Tarasiewicz, Megan Burnett, Farias-Eisner, Robin]
通讯作者:
Farias-Eisner, Robin
DOI:
10.1001/jamainternmed.2019.2205
发表时间:
2019-08
期刊:
JAMA internal medicine
影响因子:
39
作者:
[W. McCarthy;Folasade P. May]
通讯作者:
W. McCarthy;Folasade P. May
DOI:
10.3892/ijo.2016.3800
发表时间:
2017-01
期刊:
International journal of oncology
影响因子:
5.2
作者:
[Gelfand R, Vernet D, Bruhn KW, Sarkissyan S, Heber D, Vadgama JV, Gonzalez-Cadavid NF]
通讯作者:
Gonzalez-Cadavid NF
Development of New Therapeutics for Pancreatic Cancer Management
-
批准号:8490000
-
项目类别:
-
资助金额:$16.75万
-
财政年份:2013
-
负责人:Richard Joseph Pietras
-
依托单位:
NEW ENDOCRINE THERAPY IN OLDER WOMEN WITH BREAST CANCER
-
批准号:2395145
-
项目类别:
-
资助金额:$11.65万
-
财政年份:1997
-
负责人:Richard Joseph Pietras
-
依托单位:
NEW ENDOCRINE THERAPY IN OLDER WOMEN WITH BREAST CANCER
-
批准号:2732623
-
项目类别:
-
资助金额:$16.39万
-
财政年份:1997
-
负责人:Richard Joseph Pietras
-
依托单位:
NEW ENDOCRINE THERAPY IN OLDER WOMEN WITH BREAST CANCER
-
批准号:6029836
-
项目类别:
-
资助金额:$16.7万
-
财政年份:1997
-
负责人:Richard Joseph Pietras
-
依托单位:
GROWTH FACTOR RECEPTOR DIRECTED THERAPY IN CANCER
-
批准号:2101602
-
项目类别:
-
资助金额:$10.43万
-
财政年份:1995
-
负责人:Richard Joseph Pietras
-
依托单位:
GROWTH FACTOR RECEPTOR DIRECTED THERAPY IN CANCER
-
批准号:2101603
-
项目类别:
-
资助金额:$10.43万
-
财政年份:1995
-
负责人:Richard Joseph Pietras
-
依托单位:
GROWTH FACTOR RECEPTOR DIRECTED THERAPY IN CANCER
-
批准号:2654120
-
项目类别:
-
资助金额:$10.43万
-
财政年份:1995
-
负责人:Richard Joseph Pietras
-
依托单位:
GROWTH FACTOR RECEPTOR DIRECTED THERAPY IN CANCER
-
批准号:2330846
-
项目类别:
-
资助金额:$10.43万
-
财政年份:1995
-
负责人:Richard Joseph Pietras
-
依托单位:
GROWTH FACTOR RECEPTOR DIRECTED THERAPY IN CANCER
-
批准号:2871803
-
项目类别:
-
资助金额:$10.43万
-
财政年份:1995
-
负责人:Richard Joseph Pietras
-
依托单位:
Biologic Factors in Triple-Negative Breast Cancer Health Disparities
-
批准号:9152251
-
项目类别:
-
资助金额:$12.41万
-
财政年份:--
-
负责人:Richard Joseph Pietras
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: